Small Cap📈 ASX: RCE
RECCE PHARMACEUTICALS LTD(ASX:RCE)
Published 26 April 2024Penny Stock Spotlight Report
RECCE PHARMACEUTICALS LTD(ASX:RCE)
Company Profile:
Recce Pharmaceuticals Limited, an Australian company, is leading the development of synthetic anti-infectives to combat antibiotic-resistant superbugs and emerging viral pathogens. Their pipeline includes RECCE 327, 435, and 529, targeting various infections with innovative mechanisms of action and 100% water solubility.
Stock Performanc
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Penny Stock Spotlight Report
A$399.00
Already a subscriber?
Sign in to read this report.
Required subscription
Penny Stock Spotlight Report
Explore emerging ASX penny stock opportunities through weekly research focused on early-stage companies, growth catalysts, and high-risk, high-potential investment ideas.
- ✓ Exclusive Weekly Penny Stock Research
- ✓ Delivered Every Monday
- ✓ Risk Rating: High Risk, High Reward
- ✓ Full Historical Report Access
A$399.00A$1500.00/ 12 months
Risk:High
Subscribe Now →
